Group 1 - In 2025, a total of 22 Chinese concept stocks listed in the US completed refinancing, raising a total of $3.03 billion. These stocks accounted for 6.83% of the total refinancing quantity and 1.68% of the total amount raised for the year [1] - All 22 Chinese concept stocks are from NASDAQ, with a significant portion listed in 2024, including companies like Wok Medical (WOK), LGCL, and STFS, which together represent nearly half of the total [1] - Three Chinese concept stocks completed refinancing in the same year they went public: EPWK, WXM, and DXST. EPWK raised $1.128 million in its IPO and $800,000 in subsequent financing, WXM raised $560,000 initially and $344,000 later, while DXST raised $500,000 at IPO and $800,000 in refinancing [3] Group 2 - The refinancing structure was primarily characterized by small-scale issuances, with 81.82% of the amounts raised being below $10 million. Only four stocks exceeded this threshold, with BTBT leading by raising $150 million through the issuance of 75 million shares at $2 each [3] - The 22 Chinese concept stocks cover 20 different sectors, indicating a diversified distribution. The only sectors with relative concentration are advertising and packaged food and meat, while other companies are spread across publishing, construction, printing, and commodity chemicals [4] - A list of the 22 companies involved in the refinancing includes notable names such as WCT, AGMH, BON, CLIK, PTLE, VSMB, WOK, CHSN, LGCL, QMMM, BTBT, CAPIRAY, STFS, ORIS, YAAS, CCTG, CHR, EPWK, WXM, DXST, AIHS, and TWG [6]
2025年美中概股再融资回顾：22家上市公司上榜 附名单
Sou Hu Cai Jing·2026-01-15 06:03